Related Experiment Video

Updated: Aug 6, 2026

Proteomic Analysis of Human Macrophage Polarization Under a Low Oxygen Environment
10:15

Proteomic Analysis of Human Macrophage Polarization Under a Low Oxygen Environment

Published on: January 7, 2019

Pyruvate dehydrogenase E3 binding protein (protein X) deficiency

R M Brown1, R A Head, A A M Morris

  • 1Genetics Unit, Department of Biochemistry, University of Oxford, Oxford, UK.

Developmental Medicine and Child Neurology
|August 15, 2006
PubMed

Insights

Pyruvate dehydrogenase (PDH) deficiency, primarily caused by PDHA1 mutations, can also result from PDX1 mutations. Defects in the E3 binding protein (E3BP) gene (PDX1) are more common than previously thought and cause less severe neurological dysfunction.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatric Neurology

Background:

  • Pyruvate dehydrogenase (PDH) deficiency is a significant cause of infant and childhood neurological dysfunction and lactic acidosis.
  • Most cases (>80%) stem from mutations in the PDHA1 gene, encoding the E1alpha subunit.
  • Defects in dihydrolipoamide dehydrogenase (E3) and E3 binding protein (E3BP) are other known contributors to PDH deficiency.

Observation:

  • Previously considered rare, mutations in PDX1, the gene for E3BP, are now recognized as relatively common.
  • Six new patients (four males, two females; age range 15 months to 6 years) with PDX1 mutations were analyzed.
  • All identified E3BP deficiency patients have mutations preventing protein synthesis.

Findings:

  • Clinical, biochemical, and genetic data from new and existing PDX1 mutation patients were compared.
  • Patients with E3BP deficiency generally present with less severe neurological impairment compared to PDHA1 mutation patients.
  • Despite severity differences, clinical and neuroradiological features show considerable overlap between E3BP and PDHA1 deficiencies.

Implications:

  • This study highlights that PDX1 mutations are a more frequent cause of PDH deficiency than previously assumed.
  • Understanding the genetic basis of PDH deficiency, including E3BP defects, aids in diagnosis and management.
  • Further research into the spectrum of PDH deficiency caused by E3BP mutations is warranted to refine prognostic indicators.

More Related Videos

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve09:13

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

Related Concept Videos

Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.